PartsTable
Technical Data Sheet
Download PDF

7198 HYPORET — VINCRISTINE SULFATE INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

7198 HYPORET: VINCRISTINE SULFATE INJECTION.

The VINCRISTINE SULFATE INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: SYRINGE, supplementary_features: ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT, protective_storage_feature: ANTINEOPLASTIC DRUG, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 1.000 MILLILITERS, active_medicament_medicinal_strength: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-227-1608, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
7198 HYPORET
NSN: 6505-01-227-1608
FSC: 6505 — Drugs and Biologicals
CAGE: 75602 — ELI LILLY AND COMPANY (USA)
SPECIFICATIONS
primary_container_typeSYRINGE
supplementary_featuresANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT
protective_storage_featureANTINEOPLASTIC DRUG
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity3
primary_container_content_quantity1.000 MILLILITERS
active_medicament_medicinal_strength1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
part_name_assigned_by_controlling_agencyVINCRISTINE SULFATE INJECTION USP 1MG/ML 1ML SYRINGE 3S
NSN6505-01-227-1608
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available VINCRISTINE SULFATE INJECTION TITLE COMPONENT PN 7198 HYPORET MFR VINCRISTINE SULFATE IN
KEY FEATURES
•
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
•
SUPPLEMENTARY FEATURES: ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: SYRINGE
•
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
•
TOTAL PRIMARY CONTAINER QUANTITY: 3
TECHNICAL CHARACTERISTICS
PRIMARY CONTAINER CONTENT QUANTITY1.000 MILLILITERS
SUPPLEMENTARY FEATURESANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPESYRINGE
PROTECTIVE STORAGE FEATUREANTINEOPLASTIC DRUG
PART NAME ASSIGNED BY CONTROLLING AGENCYVINCRISTINE SULFATE INJECTION USP 1MG/ML 1ML SYRINGE 3S
ACTIVE MEDICAMENT MEDICINAL STRENGTH1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
TOTAL PRIMARY CONTAINER QUANTITY3
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 2
NDC00002-7198-09Reference document
Same NSN cross-reference
Reference document — Secondary reference
ONCOVIN HYPORETReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
HAZMAT per U.S. Government catalogShelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required
Ready to buy 7198 HYPORET?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is 7198 HYPORET?
7198 HYPORET is a VINCRISTINE SULFATE INJECTION.
What parts can replace 7198 HYPORET?
There are 2 known substitutes for 7198 HYPORET: NDC00002-7198-09, ONCOVIN HYPORET. Substitute compatibility should be verified for your specific system.
What is the NSN for 7198 HYPORET?
7198 HYPORET is cataloged in the U.S. Government catalog under NSN 6505-01-227-1608. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — 7198 HYPORET